Related references
Note: Only part of the references are listed.The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: A literature review
Kerrie Westaway et al.
DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE (2020)
Fourteen-Year Trends in the Use of Psychotropic Medications, Opioids, and Other Sedatives Among Institutionalized Older People in Helsinki, Finland
Hanna-Maria Roitto et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2019)
An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses
Lorraine J. Phillips et al.
JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING (2018)
National Prescribing Trends for High-Risk Anticholinergic Medications in Older Adults
Taeho Greg Rhee et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Use of Anticholinergic Drugs and its Relationship With Psychological Well-Being and Mortality in Long-Term Care Facilities in Helsinki
Ulla Liisa Aalto et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2018)
Use of Bladder Antimuscarinics in Older Adults with Impaired Cognition
Ariel R. Green et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
Trends in potentially inappropriate medication prescribing to nursing home patients: comparison of three cross-sectional studies
Kjell H. Halvorsen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study
Francisca M. Scoralick et al.
PSYCHOGERIATRICS (2017)
Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study
Francisca M. Scoralick et al.
PSYCHOGERIATRICS (2017)
Antiseizure, antidepressant, and antipsychotic medication prescribing in elderly nursing home residents
Sai Praneeth R. Bathena et al.
EPILEPSY & BEHAVIOR (2017)
Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway
Amura Francesca Fog et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2017)
Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data
Joshua Niznik et al.
DRUGS & AGING (2017)
Trends in Prevalence and Determinants of Potentially Inappropriate Prescribing in the United States: 2007 to 2012
Marcela Jiron et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Anticholinergic Drug Burden in Persons with Dementia Taking a Cholinesterase Inhibitor: The Effect of Multiple Physicians
Christina E. Reppas-Rindlisbacher et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Impact of Multiple Low-Level Anticholinergic Medications on Anticholinergic Load of Community-Dwelling Elderly With and Without Dementia
Karen E. Mate et al.
DRUGS & AGING (2015)
The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature
Karen Cardwell et al.
DRUGS & AGING (2015)
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
Mohammed Saji Salahudeen et al.
BMC GERIATRICS (2015)
Use of Drugs with Anticholinergic Properties Among Nursing Home Residents with Dementia: A National Analysis of Medicare Beneficiaries from 2007 to 2008
Jacqueline B. Palmer et al.
DRUGS & AGING (2015)
Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data
Deepa Sumukadas et al.
AGE AND AGEING (2014)
Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review
Chris Fox et al.
AGE AND AGEING (2014)
Trends in Inappropriate Drug Therapy Prescription in the Elderly in Sweden from 2006 to 2013: Assessment Using National Indicators
Bo Hovstadius et al.
DRUGS & AGING (2014)
Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes
Hege Kersten et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Ten-Year Trajectory of Potentially Inappropriate Medications in Very Old Women: Importance of Cognitive Status
Alain Koyama et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2013)
Institutionalization as a Risk Factor for Inappropriate Drug Use in the Elderly: A Swedish Nationwide Register-Based Study
Ylva Haasum et al.
ANNALS OF PHARMACOTHERAPY (2012)
The use of medications with anticholinergic properties and risk factors for their use in hospitalised elderly patients
Martin Wawruch et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Use of Anticholinergic Drugs and Cholinesterase Inhibitors and Their Association with Psychological Well-Being Among Frail Older Adults in Residential Care Facilities
Mariko Teramura-Gronblad et al.
ANNALS OF PHARMACOTHERAPY (2011)
STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation
P. Gallagher et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
The anticholinergic risk scale and anticholinergic adverse effects in older persons
James L. Rudolph et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Antidepressants for the Treatment of Insomnia A Suitable Approach?
Michael H. Wiegand
DRUGS (2008)
Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland - A cross-sectional study
Helka M. V. Hosia-Randell et al.
DRUGS & AGING (2008)
Anticholinergic activity of 107 medications commonly used by older adults
Marci L. Chew et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity
Ryan M. Carnahan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)